Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Are These Four Stocks Gaining Ground on Monday?

Page 1 of 2

The major indices have lost over 1% so far on Monday, but several stocks are making big moves in the opposite direction, registering significant gains fueled by positive developments. Among the market leaders, Iconix Brand Group Inc (NASDAQ:ICON), Relypsa Inc (NASDAQ:RLYP), Impax Laboratories Inc (NASDAQ:IPXL), and XOMA Corp (NASDAQ:XOMA) are trading significantly higher today. Let’s take a closer look at these stocks and the news that sparked their upward trend.

stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart


In addition, we will take a look at the smart money sentiment toward these four stocks, which could serve as a predictor regarding their long-term profitability. These funds usually invest large amounts of capital, which is why they spend considerable resources in their research process. The focus on the long-term horizon is what makes these investors perfect to emulate. On average, imitating the 50 most popular stocks among smart money investors slightly underperformed the market in our backtests. On the other hand, following these funds into their best small-cap ideas can beat the market by double digits each year. Our strategy follows the 15 most popular small-caps among over 730 funds and it has returned 102% since August 2012, outperforming the S&P 500 ETF (SPY) by around 53 percentage points (see more details here).

Let’s start with the top gainer, XOMA Corp (NASDAQ:XOMA), whose stock has surged by over 37% so far today and seems to be heading even higher. Today’s gains have offset the 29% drop on Friday on the back of weaker-than-expected financial results for the third quarter. The company posted a flat profit for the quarter, compared to a loss of $0.17 per diluted share reported a year earlier. However, its revenue declined to $2.07 million from $5.14 million. On the back of the results, Piper Jaffray and Jefferies Group raised their price targets on XOMA Corp (NASDAQ:XOMA) to $1.80 and $1.50 respectively, but maintained ‘Neutral’ and ‘Hold’ ratings. Factoring in today’s growth, XOMA Corp (NASDAQ:XOMA)’s stock is 65% down year-to-date, but the funds from our database are bullish on the stock, with 30 investors holding over 31% of the company at the end of June.

Follow Xoma Corp (NASDAQ:XOMA)
Trade (NASDAQ:XOMA) Now!

Iconix Brand Group Inc (NASDAQ:ICON)‘s shares have appreciated by more than 13%, which also helped the stock to recover from the 57% drop on Friday, which came on the back of the announcement that the company plans to restate some of its historical financial statements and the disclosure of preliminary results for the third quarter and guidance for the full year. Iconix Brand Group Inc (NASDAQ:ICON) posted a net loss of $0.13 per diluted share, compared to a profit of $0.58 a year earlier. However, the non-GAAP EPS of $1.10 were substantially above the $0.52 expected by analysts, while revenue of $88.94 million, declined by 19% on the year, and was below the estimates of $105.67 million. For the current and next year, Iconix Brand Group Inc (NASDAQ:ICON) expects non-GAAP EPS in the ranges of $1.35 to $1.40 and $1.35 to $1.50 respectively. Among the investors we track, 18 held stakes equal to 15.70% of the company in aggregate at the end of the second quarter.

Follow Iconix Brand Group Inc. (NASDAQ:ICON)
Trade (NASDAQ:ICON) Now!

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!